Elevated ASPN expression is associated with poorer prognosis in gastric cancer, suggesting potential as a therapeutic target.
Elevated ASPN expression across cancers is associated with poorer prognosis, highlighting its potential as a prognostic biomarker and therapeutic target, particularly in gastric cancer.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Discover Oncology